Cart
sales@molnova.com
Home - Products - Others - Other Targets - Cinobufotenine

Cinobufotenine

CAS No. 60657-23-0

Cinobufotenine( Bufoteninium )

Catalog No. M29116 CAS No. 60657-23-0

Cinobufotenine is a parasympathetic ganglia stimulant and is competitively antagonized by hexamethonium.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1497 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Cinobufotenine
  • Note
    Research use only, not for human use.
  • Brief Description
    Cinobufotenine is a parasympathetic ganglia stimulant and is competitively antagonized by hexamethonium.
  • Description
    Cinobufotenine is a parasympathetic ganglia stimulant and is competitively antagonized by hexamethonium.(In Vitro):The activity of Cinobufotenine in guinea pig ileum is 1.5 times higher than that of Coryneine, but the activity of Coryneine in frog rectus muscle is 2.7 times higher than that of Cinobufotenine.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Bufoteninium
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    60657-23-0
  • Formula Weight
    219.307
  • Molecular Formula
    C13H19N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[N+](C)(C)CCc1c[nH]c2ccc(O)cc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Mogroside III

    Mogroside III is a triterpenoid glycoside and a nonsugar sweetener. Mogroside III is transformed by human intestinal bacteria to release secondary glycoside mogroside IIA1 and aglycone mogrol.

  • m-PEG16-alcohol

    m-PEG16-alcohol is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.

  • GSK-626616

    GSK-626616 is a potent and orally bioavailable DYRK3 inhibitor (IC50: 0.7 nM). It inhibits other members of the DYRK family with similar potency. GSK-626616 is a potential therapy for the treatment of anemia.

Sign In Join Free